Moderna (NASDAQ:MRNA | MRNA Price Prediction) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement. But the underlying ...

Investors can find much better opportunities.

Pfizer Inc. said a new version of its bestselling Prevnar vaccine may provide infants with better protection against common ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 10:00 AM EDTCompany ParticipantsLavina Talukdar - Senior VP ...

Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting gave a peek at anticipated datasets from Merck, ...

The fall-winter COVID-19 vaccine designed to counter XBB, a subvariant of the Omicron strain, is now available nationwide for ...

China said it would bolster vaccination among its senior citizens, a move regarded by health experts as crucial to reopening ...

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV ...

"When the vaccines first came out, it was the Pfizer vaccine and there were lots of challenges with the transportation of that vaccine," Kit Young Hoon said. "And so it was not fe ...

Follow the pace of COVID-19 cases, vaccinations in Canada The debate over mandatory COVID-19 vaccines for health-care workers is on across the world as more countries move forward with the ...

May 20 (Reuters) - Pfizer said on Wednesday its experimental pneumococcal vaccine showed significantly stronger immune response than its current shot, including up to 15-fold higher antibody levels ...

Moderna Inc.’s experimental flu shot made with mRNA technology will be reviewed by a Food and Drug Administration advisory ...